Back to ABIVAXInsider 
Company
TRUFFLE CAPITAL SAS — ABIVAX
Filing 2023DD914258Published 9 Jun 2023France public disclosures
InitialEffective
Summary
TRUFFLE CAPITAL SAS
Philippe Pouletty, Membre du Conseil d'Administration
ABIVAX
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyABIVAX
ISINFR0012333284
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€0.00
Reported sales
€3,869,833.38
Net buy/sell
-€3,869,833.38
Other reported value
€0.00
Gross reported value
€3,869,833.38
Transactions
1
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 7 Jun 2023 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 224,729 | €17.22 | €3,869,833.38 | XPAR |
Sell
Execution date7 Jun 2023Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 224,729
- Unit price
- €17.22
- Total
- €3,869,833.38
Evidence
- AMF · France2023DD914258
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.